Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.


The Atlantic
Accessed 22 Aug 2020
[No new, unique, relevant content]


Accessed 22 Aug 2020
Coronavirus vaccine: Short cuts and allegations of dirty tricks in race to be first
By Gordon Corera Security correspondent
22 Aug 2020
When Moscow announced on 11 August it had registered the first vaccine against Covid-19 and was naming it Sputnik V, the message was hard to miss. Back in 1957, the Soviet Union had launched the Sputnik satellite and won the race for space. Now, Russia was saying it was pushing the boundaries of medical science.
But critics claimed it was pushing too hard. And the scepticism with which the announcement was met is a reminder of intense international competition. In this race, there have been accusations of short-cuts, espionage, unethical risk-taking and jealousy, amid talk of “vaccine nationalism”…


The Economist
Accessed 22 Aug 2020
A mixed prognosis – The covid-19 pandemic will be over by the end of 2021, says Bill Gates
But millions of deaths are yet to come in poor countries
Aug 18th 2020
MILLIONS MORE are going to die before the covid-19 pandemic is over. That is the stark message of Bill Gates, a co-founder of Microsoft and one of the world’s largest philanthropists via the Bill & Melinda Gates Foundation, in an interview with Zanny Minton Beddoes, The Economist’s editor-in-chief, in early August. Most of these deaths, he said, would be caused not by the disease itself, but by the further strain on health-care systems and economies that were already struggling. He also lamented the politicisation of the response to the virus in America, and the spread of conspiracy theories—some implicating him—both of which have slowed efforts to contain the disease’s spread. But he offered reasons for hope in the medium term, predicting that by the end of 2021 a reasonably effective vaccine would be in mass production, and a large enough share of the world’s population would be immunised to halt the pandemic in its tracks…


Financial Times
Accessed 22 Aug 2020
Coronavirus treatment
CureVac vows ‘ethical margin’ on price of Covid-19 vaccine
Pharma group plans to make mRNA-based inoculation in Germany and ship it worldwide
August 16, 2020
CureVac, one of the pharmaceutical groups developing a potential vaccine for Covid-19, has ruled out selling its inoculation at cost, arguing instead for an “ethical margin” for shareholders. The German company raised $213m in a US stock market listing on Friday and will put the money towards conducting trials for the vaccine.
CureVac’s approach uses messenger RNA technology, which aims to transcribe some of the pathogen’s genetic code into human cells in order to help them detect it. No mRNA vaccine has been approved by regulators, though rivals Moderna and Pfizer, along with the latter’s German partner BioNTech, are betting on it. CureVac says its jab could require lower doses.
“That would allow us to give a competitive price while still preserving some ethical margin,” said Pierre Kemula, the company’s chief financial officer, in an interview with the Financial Times…
Bottom of Form


Accessed 22 Aug 2020
Editors’ Pick  |  
9 hours ago
Trump Suggests ‘Deep State’ At FDA Is Delaying Covid-19 Coronavirus Vaccine Testing
Trump also tweeted about the FDA’s hydroxychloroquine decision.
By Bruce Y. Lee Senior Contributor


Foreign Affairs
Accessed 22 Aug 2020
Essay September/October 2020
The Tragedy of Vaccine Nationalism
Global cooperation on vaccine allocation would be the most efficient way to disrupt the spread of the virus
Thomas J. Bollyky and Chad P. Bown


Foreign Policy
Accessed 22 Aug 2020 |
[No new, unique, relevant content]


The Guardian
Covid-19 will be around for ever, says former UK chief scientific …
14 hours ago Prof Mark Walport says regular vaccinations are likely to be required to control coronavirus.


New Yorker
Accessed 22 Aug 2020
[No new, unique, relevant content]


New York Times
Accessed 22 Aug 2020
Exclusive: Nearly a Fifth of Enrollees in Pfizer, BioNTech COVID-19 Vaccine Study Are Black or Latino
Nearly a fifth of 11,000 people enrolled so far in a 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer and German partner BioNTech are Black or Latino, groups among the hardest hit by the coronavirus virus pandemic, a top Pfizer executive said.
By Reuters Aug 22

China Giving Experimental Coronavirus Vaccines to High-Risk Groups Since July, Says Official
China has been giving experimental coronavirus vaccines to groups facing high infection risks since July, a health official told state media.
By Reuters Aug 22

Argentina Joins Chinese Coronavirus Vaccine Trial, Maker Says
Argentina joined Peru, Morocco and the United Arab Emirates in approving Phase 3 clinical trials for a coronavirus vaccine developed by China National Biotec Group (CNBG), the company said late Friday.
By Reuters Aug 22

Russia Approves Trial of AstraZeneca COVID-19 Vaccine: Registry Filing
Britain’s AstraZeneca has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine in Russia, a filing in the Russian registry of clinical trials showed on Friday.
By Reuters Aug 21

Australia’s Prime Minister Announces Coronavirus Vaccine Deal
Prime Minister Scott Morrison of Australia signed a deal with the drugmaker AstraZeneca to manufacture a coronavirus vaccine and provide it free to 25 million Australians.
By The Associated Press Aug 19

New Measures Aim to Boost Vaccine Rates for Flu and Children’s Shots
Pharmacists may now vaccinate young children under a new federal emergency rule aimed at helping families who missed well-child visits during the pandemic.
By Jan Hoffman
PRINT EDITION |August 21, 2020, Page A7

Coronavirus Crisis Has Made Brazil an Ideal Vaccine Laboratory
Widespread contagion, a deep bench of scientists and a robust vaccine-making infrastructure have made Brazil an important player in the quest to find a vaccine.
By Manuela Andreoni and Ernesto Londoño
PRINT EDITION August 16, 2020,


Washington Post
Accessed 22 Aug 2020
Trump without evidence accuses ‘deep state’ at FDA of slow-walking coronavirus vaccines
Laurie McGinley, Carolyn Y. Johnson and Josh Dawsey · Health · Aug 22, 2020